History in perspective: How Alzheimer's Disease came to be where it is?

Amyloid-β in Alzheimer’s Disease: A Study of Citation Practices of the Amyloid Cascade Hypothesis Between 1992 and 2019

(2020) Timothy Daly et al.   JOURNAL OF ALZHEIMERS DISEASE

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics

(2020) Sarah A. Kent et al.   ACTA NEUROPATHOLOGICA

Role of tau protein in Alzheimer's disease: The prime pathological player

(2020) Shibi Muralidar et al.   INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES

Oxford Brain Diagnostics: turning MRI into a diagnosis tool for dementia

(2020) Simon Makin   NATURE

Synergy between amyloid-β and tau in Alzheimer’s disease

(2020) Marc Aurel Busche et al.   NATURE NEUROSCIENCE

Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers

(2020) Petrice M. Cogswell et al.   NEUROIMAGE

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

(2019) Oskar Hansson et al.   Alzheimers Research & Therapy

Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

(2019) Jinny Claire Lee et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease

(2019) Nour M. Moussa‐Pacha et al.   MEDICINAL RESEARCH REVIEWS

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study

(2019) Ya-Nan Ou et al.   Alzheimers Research & Therapy

Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of Aging

(2019) Dimitrios Kapogiannis et al.   JAMA Neurology

Incremental value of amyloid-PET versus CSF in the diagnosis of Alzheimer’s disease

(2019) Matteo Cotta Ramusino et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways

(2019) Steven M. Greenberg et al.   Nature Reviews Neurology

Friend, Foe or Both? Immune Activity in Alzheimer’s Disease

(2019) Georgia R. Frost et al.   Frontiers in Aging Neuroscience

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Biomarkers for Alzheimer's disease: current status and prospects for the future

(2018) K. Blennow et al.   JOURNAL OF INTERNAL MEDICINE

The heterogeneity within Alzheimer's disease

(2018) Daniel Ferreira et al.   Aging-US

Molecular Pathogenesis of the Tauopathies

(2018) Jürgen Götz et al.   Annual Review of Pathology-Mechanisms of Disease

Congo Red and amyloids: history and relationship

(2018) Elmira I. Yakupova et al.   BIOSCIENCE REPORTS

Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic

(2018) Harald Hampel et al.   Nature Reviews Neurology

The Early Events That Initiate β-Amyloid Aggregation in Alzheimer’s Disease

(2018) Xingyu Zhang et al.   Frontiers in Aging Neuroscience

Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer’s Biomarkers in Daily Practice (ABIDE) Project

(2017) Ingrid S. van Maurik et al.   JAMA Neurology

What is the evidence that tau pathology spreads through prion-like propagation?

(2017) Amrit Mudher et al.   Acta Neuropathologica Communications

Cerebrospinal Fluid Tau Protein Levels and 18F-Fluorodeoxyglucose Positron Emission Tomography in the Differential Diagnosis of Alzheimer’s Disease

(2017) Igor Yakushev et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis

(2016) Bob Olsson et al.   LANCET NEUROLOGY

A Brief History of Tau

(2015) M. Goedert et al.   CLINICAL CHEMISTRY

The genetic landscape of Alzheimer disease: clinical implications and perspectives

(2015) Caroline Van Cauwenberghe et al.   GENETICS IN MEDICINE

Advances in MRI biomarkers for the diagnosis of Alzheimer's disease

(2014) Elizabeth G Kehoe et al.   Biomarkers in Medicine

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Early detection of Alzheimer's disease using PiB and FDG PET

(2014) Ann D. Cohen et al.   NEUROBIOLOGY OF DISEASE

Imaging as a biomarker in drug discovery for Alzheimer’s disease: is MRI a suitable technology?

(2014) Emilio Merlo Pich et al.   Alzheimers Research & Therapy

Fluorine-18 Radiolabeled Heterocycles as PET Tracers for Imaging β - Amyloid Plaques in Alzheimer’s Disease

(2013) Fanxing Zeng et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Revised NIA-AA criteria for the diagnosis of Alzheimer's disease: a step forward but not yet ready for widespread clinical use

(2011) Giovanni B. Frisoni et al.   INTERNATIONAL PSYCHOGERIATRICS

Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

(2010) Geert De Meyer   ARCHIVES OF NEUROLOGY

The clinical use of structural MRI in Alzheimer disease

(2010) Giovanni B. Frisoni et al.   Nature Reviews Neurology

Alzheimer and his disease: a brief history

(2010) Gabriele Cipriani et al.   NEUROLOGICAL SCIENCES

Propagation of Tau Misfolding from the Outside to the Inside of a Cell

(2009) Bess Frost et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The future of amyloid-beta imaging: a tale of radionuclides and tracer proliferation

(2008) William E Klunk et al.   CURRENT OPINION IN NEUROLOGY

Imaging amyloid deposition in Lewy body diseases

(2008) S. N. Gomperts et al.   NEUROLOGY